Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-07T21:16:29.173Z Has data issue: false hasContentIssue false
  • English
  • Français

Eye disease in the elderly

Published online by Cambridge University Press:  17 November 2008

EE Kritzinger
EE Kritzinger*
Affiliation:
Birmingham & Midland Eye Hospital, Birmingham, UK
*
EE Kritzinger, Birmingham & Midland Eye Hospital, Church Street, Birmingham B3 2NS, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 5 , Issue 4 , November 1995 , pp. 383 - 398
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Sorsby, A. Rep. public health med. subj. no. 128. London: HMSO, 1972. (Cited by Ghafour IM et al., 1983.)Google ScholarPubMed
2Ghafour, JM, Allan, D, Foulds, WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983; 67: 209–13.CrossRefGoogle ScholarPubMed
3Leibowitz, HM, Krueger, DE, Maunder, LR et al. The Framingham eye study monograph: an opthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration and visual acuity in a general population of 2631 adults. Surv Ophthalmol 1980; 24 (suppl): 335–610.Google Scholar
4Wormald, RPL, Wright, LA, Courtney, P, Beaumont, B, Haines, AP. Visual problems in the elderly population and implications for services. BMJ 1992; 304: 1226–29.CrossRefGoogle ScholarPubMed
5Trevor-Roper, P. The world through blunted sight. London: Penguin, 1988.Google Scholar
6Jay, J, Devlin, M. The increasing frequency of surgery for cataract. Eye 1990; 4: 127–32.CrossRefGoogle ScholarPubMed
7Courtney, P. The national cataract surgery survey: 1. Method and descriptive features. Eye 1992; 6: 487–92.CrossRefGoogle Scholar
8Jay, JL, Chakraborti, HS, Morrison, JD. Quality of vision through diffractive bifocal intraocular lenses. Br J Ophthalmol 1991; 75: 359–66.CrossRefGoogle ScholarPubMed
9Cheng, H. Causes of cataract. Age, sugars and probably ultraviolet B-radiation. BMJ 1989; 298: 1470–71.CrossRefGoogle Scholar
10Klein, R, Klein, BEK, Jensen, MS et al. The relation of socioeconomic factors to age-related cataract, maculopathy and impaired vision. The Beaver dam eye study. Ophthalmol 1994; 101: 1969–79.CrossRefGoogle ScholarPubMed
11West, DK, Rosenthal, FS, Bressler, SB et al. Exposure to sunlight and other risk factors for age related macular degeneration. Arch Ophthalmol 1989; 107: 875–79.Google Scholar
12Taylor, HR. Long-term effects of visible light on the eye. Arch Ophthalmol 1992; 110: 99–104.Google Scholar
13Seddon, JM, Christen, WG, Manson, JE, Buring, JE, Sperduto, RD, Hennekens, CH. Low-dose aspirin and risks of cataract in a randomised trial of US physicians. Arch Ophthalmol 1991; 109: 252–55.CrossRefGoogle Scholar
14Berry, DD, van Buskirk, EM, Shields, MB. Betaxolol and timolol. A comparison of efficacy and side effects. Arch Ophthalmol 1984; 102: 42–45.Google Scholar
15Hitchings, RA. Perimetry – back to the future? [Editorial]. Br J Ophthalmol 1994; 78: 805–806.Google Scholar
16Macular Photocoagulation Study Group. Argon laser photocoagaulation for neovascular maculopathy. Five year results from randomised clinical trials. Arch Ophthalmol 1991; 109: 1109–14.CrossRefGoogle Scholar
17Yannuzzi, LA, Slakter, JS, Sorenson, JA, Guyer, DR, Orlock, DA. Digital indocyanine green videoangiography and choroidal neovascularisation. Retina 1992; 12: 191–213.CrossRefGoogle Scholar
18Grizzard, WS, Beck, RW. Twin study of age related macular degeneration. Invest Ophthalmol Vis Sci 1994; 35: 4–.Google Scholar
19Seddon, J, Ajani, U, Sperduto, R et al. Dietary fat intake and age related macular degeneration. Invest Ophthalmol Vis Sci 1994; 35: 2003–.Google Scholar
20Vingerling, JR, Dielemans, I, Bots, ML et al. Atherosclerosis is associated with late age related maculopathy. Invest Ophthamol Vais Sci 1994; 35: 2003–.Google Scholar
21Lee, Y, Lanar, M, Jacques, P, Taylor, A. The relatoinship between long term Vitamin C intake and the presence of macular drusen. Invest Ophthalmol Vis Sci 1994; 35: 2004–.Google Scholar
22Klein, R, Klein, BEK, Moss, SE, Davis, MD, De Mets, DL. The Wisconsin epidemiological study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527–32.CrossRefGoogle ScholarPubMed
23Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Am J Ophthalmol 1978; 85: 82–106.Google Scholar
24Early Treatment Diabetic Retinopathy Study Research Group. ETDRS Report No. 2. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Ophthalmology 1987; 94: 761–74.CrossRefGoogle Scholar
25Krans, HMJ, Porta, M, Keen, H. Diabetes care and research in Europe: the St. Vincent Declaration action programme. Copenhagen: WHO, 1992.Google Scholar
26Kritzinger, EE. Management of diabetic maculopathy. Semin Ophthalmol 1986; 1: 171–78.CrossRefGoogle Scholar
27Aaberg, TM, Abrahams, GW. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology 1987; 94: 775–79.CrossRefGoogle ScholarPubMed
28Diabetic Retinopathy Vitrectomy Study Research Group. Report no. 5. Early vitrectomy for severe vitreous haemorrhage in diabetic retinopathy. Four-year results of a randomised trial. Arch Ophthalmol 1990; 108: 958–64.Google Scholar
29Kohner, EM. The effect of diabetic control on diabetic retinopathy. Eye 1993; 7: 309–11.CrossRefGoogle ScholarPubMed
30The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Eng J Med 1993; 329: 977–86.CrossRefGoogle Scholar
31Goldberg, MF, Jampol, L. Knowledge of diabetic retinopathy before and 18 years after the Airlie House Symposium on treatment of diabetic retinopathy. Ophthalmology 1987; 94: 741–46.CrossRefGoogle ScholarPubMed
32Lightman, S. Does aldose reductase have a role in the development of the ocular complications in diabetes? Eye 1993; 7: 238–41.Google Scholar
33Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy. ETDRS report no. 8. Opthalmology 1991; 98: 757–65.CrossRefGoogle Scholar
34Brahams, D. Medicine and the law: eye monitoring in diabetes. Lancet 1992; 339: 863–64.CrossRefGoogle Scholar
35MacCuish, AC. Early detection and screening for diabetic retinopathy. Eye 1993; 7: 254–59.Google Scholar
36Kritzinger, EE. Blind ignorance [Editorial]. Pract Diabetes 1990; 7: 100.CrossRefGoogle Scholar
37Keenan, JM, Kritzinger, EE, Dodson, PM. Management of retinal vein occlusion. Br J Hosp Med 1993; 49: 268–73.Google ScholarPubMed
38Dodson, PM, Kritzinger, EE. Management of retinal vein occlusion. BMJ 1987; 295: 1434–35.CrossRefGoogle ScholarPubMed
39Dodson, PM, Galton, DJ, Hamilton, AM, Blach, RK. Retinal vein occlusion and the prevalence of lipoprolein abnormalities. Br J Ophthalmol 1982; 66: 161–64.CrossRefGoogle Scholar
40Dodson, PM, Kubicki, AJ, Taylor, KG, Kritzinger, EE. Medical conditions underlying recurrence of retinal vein occlusion. Br J Ophthalmol 1985; 69: 493–96.Google Scholar
41Dodson, PM, Westwick, J, Marks, G, Kakkar, VV, Galton, DJ. B-thromboglobulin and platelet factor 4 levels in retinal vein occlusion. Br J Ophthalmol 1983; 67: 143–46.CrossRefGoogle Scholar
42Dodson, PM, Kritzinger, EE. Underlying medical conditions in young patients and ethnic differences in retinal vein occlusion. Trans Ophthalmol Soc U K 1985; 104: 114–19.Google ScholarPubMed
43Margalal, LE, Brown, GC, Angsberger, JJ et al. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central 26 retinal vein obstruction. Ophthalmology 1982; 89: 780–84.CrossRefGoogle Scholar
44Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1985; 99: 218–19.CrossRefGoogle Scholar
45Branch Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorrhage in branch vein occlusion: a randomised trial. Arch Ophthalmol 1986; 104: 34–41.Google Scholar
46Miyamoto, H, Ogura, Y, Honda, Y. Long term results of hyperbaric oxygen therapy for macular edema after retinal vein occlusion. Invest Ophthalmol Vis Sci 1993; 34: 841.Google Scholar
47Skidmore, EC, Spoor, TC, McHenry, JG. Optic nerve decompression for central retinal vein occlusion. Invest Ophthalmol Vis Sci 1994; 35: 2086–.Google Scholar
48Morrell, AJ, Thompson, DA, Gibson, JM, Kritzinger, EE, Drasdo, N. Electroretinography as a prognostic indicator of neovascularisation in CRVO. Eye 1991; 5: 362–68.CrossRefGoogle ScholarPubMed
49Sandor, EV, Millman, A, Croxon, TS, Mildvan, D. Herpes zoster ophthalmicus in patients at risk for AIDS. Am J Ophthalmol 1986; 101: 153–55.Google Scholar
50Marsh, RJ, Cooper, M. Ophthalmic herpes zoster. Eye 1993; 7: 350–70.CrossRefGoogle ScholarPubMed